Livewire spoke with Nick Griffin at K2, about the trend of obesity

Livewire Exclusive

Livewire Markets

Livewire spoke with Nick Griffin at K2, about the trend of obesity. Nick said The global population is getting fatter every year... it's a time bomb for government healthcare expenditures. He says that K2 are investing in companies who are generating profits by encouraging people to live a healthy lifestyle like Nike, Adidas and Lululemon. Governments are inevitably going to attack this problem via preventative medicine with a range of initiatives to encourage exercise, like compulsory sport at all schools. Nike is our biggest investment in that area at the moment and all of them have significant tailwinds. Charlie Aitken, Managing Director at Bell Potter agrees with Griffin (in a note he released back in August 2013 entitled Diabesity) and recommends buying GI Dynamics (ASX: GID), Mesoblast (ASX: MSB) and Resmed (ASX: RMD) and holding them for the next few years as this theme starts to play out.

Livewire Exclusive
Livewire Markets

Livewire Exclusive brings you exclusive content from a wide range of leading fund managers and investment professionals.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.


Please sign in to comment on this wire.

trending on livewire
Get the best of Livewire by signing up to our popular daily newsletter